Trials / Completed
CompletedNCT05943405
The Disease Severity In Patients With Psoriasis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Universitas Sebelas Maret · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This observational study aims to evaluate new markers to predict disease activity in psoriasis. The main question is SGOT, SGPT, GGT, hs-CRP, and apo B related to disease severity in psoriasis.
Detailed description
Psoriasis patients who had signed an informed consent were assessed for PASI scores and 5 cc of blood was drawn for GGT, hs-CRP, and apo B examinations. A PASI score is a tool used to measure the severity and extent of psoriasis. PASI is an acronym for Psoriasis Area and Severity Index.
Conditions
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2022-12-30
- Completion
- 2022-12-30
- First posted
- 2023-07-13
- Last updated
- 2023-07-13
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT05943405. Inclusion in this directory is not an endorsement.